Mitsubishi UFJ Asset Management Co. Ltd. Purchases Shares of 148,853 Revvity Inc. $RVTY

Mitsubishi UFJ Asset Management Co. Ltd. purchased a new position in Revvity Inc. (NYSE:RVTY) in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 148,853 shares of the company’s stock, valued at approximately $16,561,000. Mitsubishi UFJ Asset Management Co. Ltd. owned approximately 0.13% of Revvity as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other large investors have also modified their holdings of RVTY. Norges Bank acquired a new stake in Revvity in the 4th quarter worth approximately $80,382,000. Bank of New York Mellon Corp purchased a new stake in Revvity during the 2nd quarter worth approximately $78,766,000. Morgan Stanley increased its stake in Revvity by 29.6% during the 4th quarter. Morgan Stanley now owns 2,844,464 shares of the company’s stock valued at $275,202,000 after purchasing an additional 650,083 shares in the last quarter. Janus Henderson Group PLC raised its holdings in shares of Revvity by 7.0% in the fourth quarter. Janus Henderson Group PLC now owns 8,161,171 shares of the company’s stock worth $789,595,000 after buying an additional 533,912 shares during the last quarter. Finally, Allspring Global Investments Holdings LLC raised its holdings in shares of Revvity by 29.0% in the first quarter. Allspring Global Investments Holdings LLC now owns 2,259,286 shares of the company’s stock worth $198,636,000 after buying an additional 507,674 shares during the last quarter. Hedge funds and other institutional investors own 86.65% of the company’s stock.

Revvity Trading Up 3.8%

Shares of Revvity stock opened at $124.02 on Friday. The company has a debt-to-equity ratio of 0.36, a current ratio of 1.80 and a quick ratio of 1.50. The firm has a fifty day moving average price of $110.94 and a 200 day moving average price of $100.20. Revvity Inc. has a 1 year low of $81.22 and a 1 year high of $124.49. The stock has a market cap of $13.84 billion, a PE ratio of 59.06, a price-to-earnings-growth ratio of 2.18 and a beta of 1.07.

Revvity (NYSE:RVTY) last posted its earnings results on Tuesday, August 4th. The company reported $1.41 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.21 by $0.20. The company had revenue of $729.69 million during the quarter, compared to the consensus estimate of $702.96 million. Revvity had a net margin of 8.16% and a return on equity of 8.34%. The firm’s quarterly revenue was down 1.3% on a year-over-year basis. During the same period in the previous year, the firm posted $1.18 earnings per share. Revvity has set its FY 2026 guidance at 5.300-5.400 EPS. Equities research analysts predict that Revvity Inc. will post 5.36 earnings per share for the current year.

Revvity Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, November 13th. Stockholders of record on Friday, October 23rd will be issued a $0.07 dividend. This represents a $0.28 annualized dividend and a dividend yield of 0.2%. The ex-dividend date of this dividend is Friday, October 23rd. Revvity’s payout ratio is 13.33%.

Analyst Upgrades and Downgrades

Several research firms recently issued reports on RVTY. Robert W. Baird set a $117.00 target price on Revvity in a research report on Wednesday, May 6th. Wolfe Research assumed coverage on Revvity in a research report on Tuesday, June 2nd. They set a “peer perform” rating for the company. Zacks Research raised Revvity from a “strong sell” rating to a “hold” rating in a research report on Tuesday, August 4th. JPMorgan Chase & Co. cut their price objective on Revvity from $96.00 to $90.00 and set a “neutral” rating on the stock in a report on Wednesday, May 6th. Finally, Sanford C. Bernstein assumed coverage on Revvity in a research note on Friday, June 26th. They issued a “market perform” rating and a $115.00 price objective for the company. Three research analysts have rated the stock with a Buy rating and twelve have assigned a Hold rating to the stock. Based on data from MarketBeat, Revvity presently has an average rating of “Hold” and a consensus target price of $108.36.

Revvity Company Profile

Revvity, Inc is a global provider of technology-enabled solutions for the life sciences, diagnostics and applied markets. The company develops and supplies a range of products and services, including reagents and consumables, laboratory instruments, workflow automation, software analytics and technical support. Its portfolio supports applications in drug discovery, genomics, cell biology research, environmental and food safety testing, industrial quality control and clinical diagnostics.

Tracing its heritage to Perkin-Elmer, founded in 1937, Revvity began trading on the New York Stock Exchange under the ticker symbol RVTY in January 2024 following a corporate rebranding.